1. Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China
- Author
-
Huijun Han, Qing Han, Lijun Song, Yujing Zhu, Xiaofeng Zeng, Yanhong Li, Wufang Qi, Yueqiu Zhang, Wenjie Zheng, Miaojia Zhang, Yi Zhao, Sheng Chen, Fengchun Zhang, Xiaoxia Zuo, Hongbin Li, Sainan Bian, Lei Zhang, Boqi Gong, Ping Zhu, Kui Zhang, Susu Liao, Chengyin Lv, Wenwen Wang, Qingjun Wu, Liyang Gu, Yunyun Fei, Xiaoqing Liu, Lifan Zhang, Yan Zhao, Qian Wang, Ting Li, Zhiyi Zhang, Lidan Zhao, Wencheng Qi, Jiaxin Zhou, Xiaochun Shi, Kuerbanjiang Yimaity, Dong Xu, Yaou Zhou, Ning Tie, Yi Liu, Gaifen Liu, Cainan Luo, Jiaying Sun, Huaxiang Wu, Shengyun Liu, Hui Luo, Huaxiang Liu, Jing Xue, Jing Wang, Lishuai Han, Lijun Wu, and Yanping Zhao
- Subjects
Adult ,Male ,medicine.medical_specialty ,China ,Epidemiology ,Cross-sectional study ,Immunology ,Population ,prevalence ,Azathioprine ,Disease ,Logistic regression ,Microbiology ,Risk Factors ,Virology ,Internal medicine ,Rheumatic Diseases ,Drug Discovery ,medicine ,Humans ,Tuberculosis ,In patient ,education ,rheumatic disease ,education.field_of_study ,business.industry ,General Medicine ,Middle Aged ,Active tuberculosis ,Confidence interval ,Infectious Diseases ,Cross-Sectional Studies ,Parasitology ,Female ,business ,medicine.drug ,Research Article - Abstract
Evidence of active tuberculosis (ATB) in patients with rheumatic diseases are research priorities but limited data from China have been reported. Research targeting patients not taking anti-TNF biologics are especially insufficient. We aimed to investigate the prevalence and risk factors of ATB in this at-risk population. We conducted a tertiary hospital-based, multi-center, cross-sectional study by using stratified multi-stage cluster sampling strategy to screen ATB in patients with rheumatic diseases. We estimated the prevalence of ATB in patients with rheumatic diseases and identified risk factors among those who were not taking anti-TNF biologic. A total of 13,550 patients with rheumatic diseases were enrolled, and the result showed the standardized prevalence of ATB according to the composition ratio of various types of rheumatic disease was 882/100000 (95% confidence interval (CI): 706-1057). Multivariable logistic regression analysis in patients not taking anti-TNF biologics showed that the independent risk factors of ATB were having systemic lupus erythematosus (SLE) (OR=2.722, 95% CI: 1.437-5.159, p=0.002), having Behcet's disease (BD) (OR= 5.261, 95% CI: 2.071-13.365, p
- Published
- 2021